Annual Working Capital
-$717.00 K
-$17.62 M-104.24%
December 31, 2023
Summary
- As of February 12, 2025, CYCC annual working capital is -$717.00 thousand, with the most recent change of -$17.62 million (-104.24%) on December 31, 2023.
- During the last 3 years, CYCC annual working capital has fallen by -$33.70 million (-102.17%).
- CYCC annual working capital is now -101.43% below its all-time high of $50.24 million, reached on December 31, 2006.
Performance
CYCC Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
-$1.44 M
-$1.96 M-376.01%
September 30, 2024
Summary
- As of February 12, 2025, CYCC quarterly working capital is -$1.44 million, with the most recent change of -$1.96 million (-376.01%) on September 30, 2024.
- Over the past year, CYCC quarterly working capital has dropped by -$721.00 thousand (-100.56%).
- CYCC quarterly working capital is now -101.83% below its all-time high of $78.65 million, reached on March 31, 2007.
Performance
CYCC Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
CYCC Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -104.2% | -100.6% |
| 3 y3 years | -102.2% | -112.4% |
| 5 y5 years | -104.7% | -112.4% |
CYCC Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -102.0% | at low | -104.0% | +59.1% |
| 5 y | 5-year | -102.0% | at low | -103.0% | +59.1% |
| alltime | all time | -101.4% | at low | -101.8% | +59.1% |
Cyclacel Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.44 M(-376.0%) |
| Jun 2024 | - | $521.00 K(-114.8%) |
| Mar 2024 | - | -$3.52 M(+390.2%) |
| Dec 2023 | -$717.00 K(-104.2%) | -$717.00 K(-124.2%) |
| Sep 2023 | - | $2.96 M(-65.3%) |
| Jun 2023 | - | $8.55 M(-26.5%) |
| Mar 2023 | - | $11.64 M(-31.1%) |
| Dec 2022 | $16.90 M(-52.4%) | $16.90 M(-28.3%) |
| Sep 2022 | - | $23.56 M(-12.9%) |
| Jun 2022 | - | $27.05 M(-10.9%) |
| Mar 2022 | - | $30.37 M(-14.5%) |
| Dec 2021 | $35.53 M(+7.7%) | $35.53 M(-10.7%) |
| Sep 2021 | - | $39.78 M(-7.7%) |
| Jun 2021 | - | $43.09 M(-9.7%) |
| Mar 2021 | - | $47.69 M(+44.6%) |
| Dec 2020 | $32.98 M(+184.4%) | $32.98 M(+36.2%) |
| Sep 2020 | - | $24.22 M(-8.3%) |
| Jun 2020 | - | $26.42 M(+156.8%) |
| Mar 2020 | - | $10.29 M(-11.3%) |
| Dec 2019 | $11.60 M(-24.4%) | $11.60 M(-15.8%) |
| Sep 2019 | - | $13.77 M(-12.0%) |
| Jun 2019 | - | $15.65 M(-11.3%) |
| Mar 2019 | - | $17.64 M(+15.0%) |
| Dec 2018 | $15.34 M(-29.8%) | $15.34 M(-8.0%) |
| Sep 2018 | - | $16.67 M(-10.8%) |
| Jun 2018 | - | $18.69 M(-8.7%) |
| Mar 2018 | - | $20.47 M(-6.3%) |
| Dec 2017 | $21.86 M(+52.3%) | $21.86 M(-7.2%) |
| Sep 2017 | - | $23.55 M(+100.8%) |
| Jun 2017 | - | $11.73 M(-9.1%) |
| Mar 2017 | - | $12.91 M(-10.1%) |
| Dec 2016 | $14.36 M(-23.7%) | $14.36 M(-15.6%) |
| Sep 2016 | - | $17.01 M(+28.8%) |
| Jun 2016 | - | $13.20 M(-17.0%) |
| Mar 2016 | - | $15.91 M(-15.4%) |
| Dec 2015 | $18.81 M(-12.5%) | $18.81 M(-12.6%) |
| Sep 2015 | - | $21.53 M(-10.2%) |
| Jun 2015 | - | $23.99 M(-10.8%) |
| Mar 2015 | - | $26.89 M(+25.0%) |
| Dec 2014 | $21.51 M | $21.51 M(-11.9%) |
| Sep 2014 | - | $24.41 M(-17.2%) |
| Jun 2014 | - | $29.50 M(+19.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $24.64 M(-11.7%) |
| Dec 2013 | $27.92 M(+192.7%) | $27.92 M(-2.9%) |
| Sep 2013 | - | $28.74 M(-6.0%) |
| Jun 2013 | - | $30.58 M(+212.7%) |
| Mar 2013 | - | $9.78 M(+2.5%) |
| Dec 2012 | $9.54 M(-50.7%) | $9.54 M(-24.6%) |
| Sep 2012 | - | $12.66 M(-15.1%) |
| Jun 2012 | - | $14.91 M(-18.9%) |
| Mar 2012 | - | $18.37 M(-5.0%) |
| Dec 2011 | $19.33 M(-21.1%) | $19.33 M(-15.4%) |
| Sep 2011 | - | $22.85 M(+39.2%) |
| Jun 2011 | - | $16.41 M(-18.2%) |
| Mar 2011 | - | $20.05 M(-18.2%) |
| Dec 2010 | $24.52 M(+413.4%) | $24.52 M(+109.2%) |
| Sep 2010 | - | $11.72 M(-12.2%) |
| Jun 2010 | - | $13.35 M(-18.4%) |
| Mar 2010 | - | $16.35 M(+242.5%) |
| Dec 2009 | $4.78 M(-76.6%) | $4.78 M(-30.8%) |
| Sep 2009 | - | $6.90 M(-5.3%) |
| Jun 2009 | - | $7.28 M(-51.1%) |
| Mar 2009 | - | $14.88 M(-27.0%) |
| Dec 2008 | $20.39 M(-58.4%) | $20.39 M(-25.7%) |
| Sep 2008 | - | $27.43 M(-19.8%) |
| Jun 2008 | - | $34.20 M(-20.7%) |
| Mar 2008 | - | $43.13 M(-12.1%) |
| Dec 2007 | $49.06 M(-2.3%) | $49.06 M(-23.7%) |
| Sep 2007 | - | $64.27 M(-6.3%) |
| Jun 2007 | - | $68.59 M(-12.8%) |
| Mar 2007 | - | $78.65 M(+56.5%) |
| Dec 2006 | $50.24 M(+2234.8%) | $50.24 M(-11.0%) |
| Sep 2006 | - | $56.45 M(-7.6%) |
| Jun 2006 | - | $61.08 M(+164.9%) |
| Mar 2006 | - | $23.05 M(+971.2%) |
| Dec 2005 | $2.15 M(-94.7%) | $2.15 M(-88.7%) |
| Sep 2005 | - | $18.98 M(-31.8%) |
| Jun 2005 | - | $27.83 M(-16.9%) |
| Mar 2005 | - | $33.49 M(-18.2%) |
| Dec 2004 | $40.93 M(-6367.5%) | $40.93 M(+73.0%) |
| Sep 2004 | - | $23.65 M(-23.3%) |
| Jun 2004 | - | $30.84 M(-15.7%) |
| Mar 2004 | - | $36.57 M(-5700.2%) |
| Dec 2003 | -$653.00 K | -$653.00 K |
FAQ
- What is Cyclacel Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals annual working capital year-on-year change?
- What is Cyclacel Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly working capital year-on-year change?
What is Cyclacel Pharmaceuticals annual working capital?
The current annual working capital of CYCC is -$717.00 K
What is the all time high annual working capital for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual working capital is $50.24 M
What is Cyclacel Pharmaceuticals annual working capital year-on-year change?
Over the past year, CYCC annual working capital has changed by -$17.62 M (-104.24%)
What is Cyclacel Pharmaceuticals quarterly working capital?
The current quarterly working capital of CYCC is -$1.44 M
What is the all time high quarterly working capital for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly working capital is $78.65 M
What is Cyclacel Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, CYCC quarterly working capital has changed by -$721.00 K (-100.56%)